Every patient deserves life-changing therapy. Abbott's next generation CRT-D solutions make it possible for you to achieve clinically meaningful outcomes:
100% of patients had a narrower QRS when SyncAV™ CRT technology was optimized1
CRT-induced QRS narrowing has been shown to improve clinical outcomes for heart failure patients2,3
30% fewer cumulative heart failure hospitalizations with SyncAV CRT technology enabled vs. patients with the technology disabled.4 41% reduction in heart failure readmissions.2 34% reduction in all-cause hospitalization readmissions.2 Average lifetime savings of $4,031 per CRT patient.2
Manuals & Technical Resources
Reimbursement & Coding
Varma N, O’Donnell D, Bassiouny M, et al. Programming cardiac resynchronization therapy for electrical synchrony: reaching beyond left bundle branch block and left ventricular activation delay. J Am Heart Assoc. 2018;7:e007489. https://www.ahajournals.org/doi/10.1161/JAHA.117.007489. Accessed January 14, 2020.
Canadian Cardiovascular Society. Clinical Significance of Electromechanical Dyssynchrony and QRS Narrowing in Patients With Heart Failure Receiving Cardiac Resynchronization Therapy. https://doi.org/10.1016/j.cjca.2018.10.019. Accessed February 25, 2019.
Okafor O, Leyva F, Zegard A, et al. Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias. J Am Heart Assoc. 2019;8:e013539. DOI:10.1161/JAHA.119.013539.
Varma, N., Gain in CRT Efficacy with Dynamic Electrical Optimization: Real World Effect of SyncAV™ CRT on Heart Failure Hospitalizations. Poster presented at EHRA. May 2020. https://esc365.escardio.org/home. Accessed May 15, 2020.
CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.